Synovus Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,713
Closed -$1.75M 1630
2019
Q3
$1.75M Sell
17,713
-847
-5% -$80.5K 0.03% 246
2019
Q2
$1.71M Sell
18,560
-12,717
-41% -$1.21M 0.03% 246
2019
Q1
$2.95M Sell
31,277
-23,496
-43% -$2.05M 0.05% 177
2018
Q4
$3.5M Sell
54,773
-2,121
-4% -$157K 0.06% 155
2018
Q3
$5.08M Buy
56,894
+6,969
+14% +$616K 0.08% 139
2018
Q2
$3.97M Buy
49,925
+8,585
+21% +$713K 0.07% 152
2018
Q1
$3.68M Sell
41,340
-2,432
-6% -$233K 0.06% 155
2017
Q4
$4.55M Sell
43,772
-9,088
-17% -$1.03M 0.08% 128
2017
Q3
$7.72M Sell
52,860
-2,411
-4% -$328K 0.15% 98
2017
Q2
$7.16M Buy
55,271
+466
+0.9% +$57.1K 0.14% 98
2017
Q1
$6.8M Buy
54,805
+1,670
+3% +$200K 0.14% 100
2016
Q4
$6.17M Buy
53,135
+5,948
+13% +$662K 0.14% 101
2016
Q3
$4.93M Buy
47,187
+22,580
+92% +$2.44M 0.12% 108
2016
Q2
$2.43M Sell
24,607
-12
-0% -$1.24K 0.06% 149
2016
Q1
$2.46M Buy
24,619
+16,048
+187% +$1.65M 0.06% 150
2015
Q4
$1.03M Buy
8,571
+1,222
+17% +$141K 0.03% 255
2015
Q3
$795K Buy
7,349
+769
+12% +$95.4K 0.02% 298
2015
Q2
$763K Sell
6,580
-2,960
-31% -$338K 0.02% 305
2015
Q1
$1.1M Sell
9,540
-54
-0.6% -$6.45K 0.03% 266
2014
Q4
$1.07M Sell
9,594
-274
-3% -$28.9K 0.03% 268
2014
Q3
$937K Buy
9,868
+3,186
+48% +$288K 0.03% 275
2014
Q2
$574K Hold
6,682
0.02% 307
2014
Q1
$466K Sell
6,682
-17,434
-72% -$1.38M 0.01% 329
2013
Q4
$2.04M Buy
24,116
+300
+1% +$23.7K 0.06% 156
2013
Q3
$1.83M Buy
23,816
+17,440
+274% +$1.22M 0.06% 152
2013
Q2
$373K Buy
+6,376
New +$384K 0.01% 323

Other funds holding CELG

Synovus Financial's CELG Position: Q4 2019 in Review

Synovus Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 17,713 shares — an estimated $1.75M sold.

Synovus Financial first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.72M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Synovus Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Synovus Financial sold 17,713 Celgene Corp shares in Q4 2019, an estimated $1.75M.
  • Synovus Financial first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Synovus Financial's Celgene Corp position peaked at $7.72M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Synovus Financial's 13F filing for Q4 2019, filed 6 Feb 2020.